Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration

Bristol Myers Squibb has partnered with a Chinese company to develop new drugs. This collaboration marks a potential next wave of cross-continent partnerships. The partnership aims to bring new treatments to market.